Skip to content
‹ Back to IndustriesSciences

Beyond Fukushima: Nuclear Energy is Critical to Achieve Net Zero

The Fukushima nuclear plant's planned release of treated radioactive water into the Pacific has renewed international debate over nuclear energy's risks and benefits. Despite ongoing concerns, nuclear power remains a critical component of global strategies to achieve net-zero carbon emissions. Nations must weigh the perceived dangers of nuclear against its proven capacity to provide low-carbon baseload electricity at scale.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Christopher Gadomski · · FukushimaFukushima Wastewater ReleaseNuclear EnergyNuclear Power
Share

Key takeaways

01

Japan's release of treated radioactive water from Fukushima has drawn international criticism, including trade restrictions from China.

02

Nuclear energy is increasingly recognized as essential to achieving net-zero emissions targets globally.

03

Policymakers must balance public risk perception of nuclear with its demonstrated value as a reliable, low-carbon energy source.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The Fukushima Nuclear plant fallout continues as nations try to balance the risks while realizing the potential and need for nuclear energy.

Japan initiated its planned release of treated radioactive water from the Fukushima nuclear plant into the Pacific, a decision that has drawn international criticism and economic consequences. In a swift response, China immediately banned all Japanese aquatic products, voicing concerns over potential radioactive contamination. This move, greenlit by the Japanese government two years prior and recently endorsed by the U.N. nuclear watchdog, is a pivotal step in decommissioning the Fukushima Daiichi plant, which suffered severe damage from a 2011 tsunami. However, with protests erupting globally and significant economic implications on the horizon, the long-term effects of this decision remain uncertain.

No matter the decision, many will wonder about its safety/efficacy by Japanese energy officials. How might this decision impact public perception around nuclear energy, especially as citizens gain a renewed interest in its place among renewable energy alternatives?

Christopher Gadomski, Lead Analyst, Nuclear for BloombergNEF, weighed in on the controversial move and its potential impact on seeking nuclear power solutions in the future.

Christopher’s Thoughts

“The level of radiation of tritium in the water is well below world standards. And so, to me, I believe that it’s something that was the right thing to do. I’m head of nuclear research for Bloomberg NEF. I teach economics and finance for New York University, the Center for Global Affairs. I visited Fukushima in 2013 or 2015, two to four years after the accident. And when I was there, you could see already hundreds of these large storage tanks that were accumulating water that had been contaminated.”

Radiation Levels and Safety Measures

“The Fukushima power plant is built on a plateau. They excavated down, and water falls from the mountains behind there through the plateau and came into the basement of the nuclear power plant, came in contact with the melted reactors, and became contaminated. And so to prevent it from running further into the sea, the engineers at Fukushima collected this water.

They put it in storage tanks, and they were contaminated by strontium, cesium, iodine, and various radionuclides. And they have to sort of deal with them. So they applied this advanced liquid processing system that came from, I believe, the Europeans or so.

And this processing took the water and removed all of the 65 radionuclides from the water. What they did not remove from the water was tritium. And they can’t remove tritium because tritium is an isotope of hydrogen.

And it’s very, very difficult to use the Alps system to remove the tritium. So you have, I understand, a thousand tanks on the site now, accumulating something like 100,000 liters of water a day. And you came to the point where you needed to do something. And so, they decided to release the water into the ocean.”

Public Perception and International Reactions

“From what the IAE, the International Atomic Energy Agency, has said, is that the level of radiation of tritium in the water is well below world standards. And so, to me, I believe that it’s something that was the right thing to do because the Japanese have spent the last ten years worrying about trying to collect and treat this water. A variety of international organizations have looked at it and said, yes, it’s below certain levels. And if we do it properly, we can release it out to the sea. It’s what the stars are doing today. When I was in Fukushima again, in 2013 or 2015, we went to a local sushi restaurant and had some fantastic sushi for dinner. And I’m still alive. I have yet to turn green. And so, you know, there is a concern because radiation is one of those things that people don’t quite understand.

We believe the World Health Organization, and we believe the International Atomic Energy Agency, the Japanese government, and TEPCO, the utility, the operating plant, that these may have reduced the danger of this water that’s being released to well below global standards. It’s like eating a couple of bananas a day because there’s a lot of potassium in bananas, which are radioactive. And so if you eat 15 bananas, that’s equivalent to some of the exposure that you would be getting if you were to be in contact with this water.

And, you know, people eat bananas every day. I had mine today. But what I think is happening is that there’s no real love lost between the Chinese, the Japanese, and Koreans on certain levels.

At certain levels, they are cooperating helping each other. On other levels, they’re competing. And so, in my estimation, the efforts by the Koreans and the Chinese, more specifically the Chinese, they’re like sticking their fingers in the Japanese eye by making a very big issue of all of this when theoretically it shouldn’t be an issue.

It’s a concern. You are releasing tritiated water. Tritium has a very short half-life.

It’s an isotope of hydrogen. It is radioactive. But to me, the problem is being blown out of proportion.”

Nuclear Energy’s Role in Achieving Net Zero

“However, it’s something that has to be calculated for all the nuclear industries. It’s another topic that we’re having a tremendous amount of coverage about this event today. And it is another negative label for the nuclear energy industry, which I think is unwarranted. It’s my opinion that if you are really trying to achieve net zero, which many countries worldwide are trying to do, nuclear has to play a key role in doing that as a complement to renewables. And this doesn’t help the public image of nuclear power because they may be releasing this water for many years to come. Everybody loves to hate nuclear power because they’re afraid of it. They don’t understand it.

I drove within 10 yards of the Fukushima reactor that was damaged. I got a slight radiation dose. I’m still here. And I think people don’t understand it. I also traveled to visit that site with some MIT scientists, and they judged the Japanese reaction to the evacuation of all the people from Fukushima as being much greater than warranted. And if you go to Chernobyl these days, I have not been there, but I understand the area is thriving with wildlife. And, you know, low radiation levels persist there, but it has not been ultimately very damaging to people. But it’s a very testy subject. And many people go back and forth and like to explain that there is a real serious problem with radiation.”

International Cooperation in Nuclear Energy

“And going back to the aspect of cooperation, there’s cooperation between General Electric and Hitachi, two leading U.S. and Japanese firms, to commercialize the next generation of nuclear. There is a lot of international cooperation. The Koreas are involved in working with other European companies and building reactors very successfully in the Middle East and working with Westinghouse at times. There are loggerheads regarding licensing the intellectual property of the reactors. But it’s very, very important. It’s a global problem, climate change, the net zero. And aspirations, I think, can only really be addressed if you have a large contribution of nuclear to complement an even larger deployment of renewables.

Yeah, I think that one of the things that I talk about and maintain is that nuclear energy is a very, very critical thing. And those companies, those countries that manage the build-out of their nuclear energy infrastructure, will play a more important role in the future than those countries that ignore it. And I’m concerned right now that the U.

S. , although it’s trying to develop many different types of advanced reactors, other countries, the Russians, and the Chinese, are more aggressive in building and reaching out and building nuclear reactors in other parts of the world. And so the U.

S. , on the surface, seems to be quite well behind the competition in Russia and China for building new reactors around the world. A cooperative agreement between the U.

S. and Japan and U. S.

and Korea to build reactors in this country and elsewhere, I think, would go a long way towards achieving the sustainability goals that we all aspire to.”

Article by James Kent

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

Christopher Gadomski
Christopher GadomskiLead Analyst, Nuclear

As a business development and marketing consultant, Mr. Gadomski has advised a wide range of clients from the Government of Egypt to IBM on strategic planning, business development, corporate communications and policy inititiatives. Mr. Gadomski is a faculty member of The Center for Global Affairs at New York University where he teaches courses on Energy Policy, Energy and the Environment, and the Economics and Finance of Energy. He has received the Mitsui Practitioner in Academia grant from The Weissman Center for International Business at the Zicklin School of Business at Baruch College, CUNY in support of syllabus development for Internet Marketing and Global Business courses he has taught there.

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Antibody developability checks are moving into discovery instead of waiting for development

Antibody developability checks are moving into discovery instead of waiting for development

Maria Gonzalez-Pajuelo of FairJourney Bio says the order in antibody discovery is changing: developability has become a much more important consideration during discovery, rather than an issue left until later-stage development. The goal, she says, is that what comes out of discovery is something CMC can take forward easily.

  • 01Discovery-stage developability screens can rank many antibodies tested once or twice and may reduce surprises later in development, while development still focuses on several lots of a single antibody and answers different questions.

Oct 1, 2026

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

Caraballo expects AI across all five tracks at ISPE’s 2026 Annual Meeting

ISPE’s 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC describing how the tracks connect—and why AI is treated as a cross-cutting topic rather than a standalone track. Deloitte’s December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE’s 2026 Annual Meeting has no dedicated AI track; executive chair Jose Caraballo expects AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte’s December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own outlook but only 41% optimistic about the global economy, a mood the story says the ISPE chairs are programming for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation using tagged models lets researchers track tumor growth in the original organ, aligning the model and delivery route with how therapies are intended to be tested.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

Christopher Gadomski
Christopher Gadomski

Research Director, Nuclear Energy at BloombergNEF (formerly)

Christopher Gadomski is a research analyst and thought leader specializing in nuclear energy and power markets. He has contributed analysis on nuclear energy policy, economics, and the role of nuclear in decarbonization strategies. His work has appeared in industry publications and he has been associated with energy research at major advisory firms including EY.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512